Winona Review

The current terms identify Winona, Inc. as the platform and expressly say it is not a healthcare provider. The telehealth consent names four Winona Medical Group entities that provide care according to the patient's residence or physical location. The assigned physician, entity, and pharmacy remain patient specific.

Current organization metadata lists an Austin address, while the current terms direct legal mail to 3723 Greenville Ave STE 83040, Dallas, Texas 75206. Because those first-party location records differ, this draft does not state a definitive headquarters.

Winona limits HRT to women ages 35 to 59 and offers care in Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, Wyoming, and Puerto Rico.

Onboarding begins with a free medical intake. Winona matches the patient to a board-certified physician licensed in the applicable state, and a prescription is issued only if the clinician finds treatment appropriate. Completing intake or paying does not guarantee a medication, dose, refill, or product.

The standard relationship is asynchronous. Winona says physicians do not conduct phone or video consultations and that all medical communication occurs through secure portal messaging. Patients can write at any time, but typical physician replies take 24 to 48 hours and may take longer.

Winona does not require routine hormone bloodwork to start menopause HRT and says physicians use symptoms and medical history. That policy is not a promise that no testing, external evaluation, identity check, or in-person care will ever be clinically necessary.

The compounded combined body cream contains estradiol USP, estriol USP, and progesterone USP and starts at $89 per month. The single card uses that full ingredient combination and transdermal cream route rather than turning the storefront phrase into a new therapy.

The FDA-approved transdermal estradiol patch starts at $149 per month. Winona lists 0.025 mg, 0.0375 mg, 0.05 mg, 0.075 mg, and 0.1 mg strengths and generally describes replacement every four days or as directed. The card keeps strength patient specific and does not infer package count.

The vaginal cream contains estradiol USP and starts at $89 per month. Winona describes a localized schedule that is often daily at first and then several times weekly. The final compound is not FDA approved even though estradiol is an ingredient used in FDA-approved products.

The progesterone body cream contains progesterone USP and starts at $89 per month. It is compounded and individualized, so the public page does not supply one concentration or universal dose. It remains distinct from oral progesterone because route and regulatory status differ.

The estrogen body cream contains estradiol USP plus estriol USP and starts at $89 per month. It is a two-ingredient compounded transdermal formula, not a generic estradiol cream and not the same record as the three-hormone combined cream.

The oral estradiol tablet starts at $54 per month and is presented as an FDA-approved finished drug taken daily. Public pages do not identify the manufacturer, exact dispensed brand or generic product, strength, count, or which supply schedule receives the starting rate.

The oral progesterone capsule starts at $39 per month and is presented as FDA approved. The ingredients list includes peanut oil and gelatin. The page does not call the product micronized or identify its manufacturer, strength, count, or National Drug Code, so this draft maps only to the broader oral progesterone catalog record.

DHEA is an oral daily capsule sold from $27 per three-month supply, equal to $9 per month. Winona calls it a supplement and prescription DHEA; it is not an FDA-approved drug. Exact strength, capsule count, and whether all patients receive the same formula are not public.

Peripheral products are not hidden, but they do not multiply the core HRT catalog. Estriol plus tretinoin face cream and 7% topical minoxidil each cost $150 per three-month supply, equal to $50 per month. Sildenafil plus pentoxifylline arousal cream costs $79 per order without a public monthly supply interval.

The Deep Sleep formula contains ramelteon 10 mg, magnesium glycinate 250 mg, and DHHB 10 mg in a chewable or sublingual tablet. Its one-month and three-month rates are $119 and $269, whose plan-level monthly equivalents average $104.33. It remains editorial-only because the combination lacks an exact reusable catalog record and is not core HRT.

Winona says there is no long-term agreement or separate subscription fee for an account. The prescription itself auto-refills every 28 days for a 30-day supply or every 84 days for a 90-day supply. A patient receiving multiple medicines pays for each prescribed product.

Using Winona's own fulfillment path includes standard shipping, clinical access, and follow-ups in the medication price. If an eligible prescription is sent to an outside pharmacy, Winona says a $50 monthly platform fee applies and the patient pays that pharmacy separately. Not every pharmacy can fill a custom compound.

Winona does not bill insurance. HSA and FSA cards are accepted, and the portal can provide receipts for possible private insurance reimbursement. The terms say Medicare, Medicaid, and other government programs do not pay for these services and patients should not submit those charges to a government plan.

After an order processes, Winona holds it for 24 hours before pharmacy fulfillment. Cancellation during that window can receive a full refund to the original payment method. After the window, customized prescriptions generally cannot be canceled, returned, redispensed, or refunded.

The FAQ says the pharmacy usually prepares an order within one to two business days and packages generally arrive within three to five business days. Free USPS Ground Advantage is listed at two to five business days after shipment; expedited choices range from $15 to $75, but delivery windows and expedited refunds are not guaranteed.

Winona says it owns and operates two 503A pharmacies and follows USP 795 and 800 standards. The current public pharmacy pages do not identify both legal pharmacy names, license numbers, accreditation, or the exact dispensing facility for a future prescription, so patients should verify those details on the label and state board record.

FDA states that compounded drugs are not FDA approved and are not reviewed before marketing for safety, effectiveness, or quality. This distinction applies to the finished Winona compounded creams even where Winona correctly identifies an active ingredient as USP grade or an ingredient also used in an approved drug.

The general privacy policy describes identifiers, commercial activity, health-related information outside clinical treatment, device data, cookies, Segment analytics, advertising, cross-site profiling, and disclosures that may qualify as sale or sharing under state privacy laws. Clinical information collected for medical providers and pharmacies is handled under separate arrangements and notices.

Katalys program 495 remains pending with a listed $62 payout and a $3.39 network-benchmark EPC. An alternate Impact route requested through Intelsio remains pending at $15 per approved sale. Neither relationship supplies a verified tracking URL, cookie, attribution rule, reversal policy, or customer promotion, so the CTA remains the ordinary first-party URL.